) Year Status Type Period As Of Audit Financial Statement MD&A Financial Statement Revise 2022 Company Year 31/01/2022 2022 Consolidated Year 31/01/2022 2022 Reviewed Company Q3 31/10/2021
Of Details INTER PHARMA PUBLIC COMPANY LIMITED 2021 Consolidated Year 31/12/2021 INTER PHARMA PUBLIC COMPANY LIMITED 2021 Company Year 31/12/2021 INTER PHARMA PUBLIC COMPANY LIMITED 2021 Reviewed
Period As Of Details QUALITECH PUBLIC COMPANY LIMITED 2023 Reviewed Company Q2 30/06/2023 QUALITECH PUBLIC COMPANY LIMITED 2023 Reviewed Consolidated Q2 30/06/2023 QUALITECH PUBLIC COMPANY LIMITED 2023
Period As Of Details U CITY PUBLIC COMPANY LIMITED 2022 Reviewed Company Q2 30/06/2022 U CITY PUBLIC COMPANY LIMITED 2022 Reviewed Consolidated Q2 30/06/2022 U CITY PUBLIC COMPANY LIMITED 2022 Reviewed
Period As Of Details PATKOL PUBLIC COMPANY LIMITED 2023 Reviewed Company Q2 30/06/2023 PATKOL PUBLIC COMPANY LIMITED 2023 Reviewed Consolidated Q2 30/06/2023 PATKOL PUBLIC COMPANY LIMITED 2023 Reviewed
peak in Q1 2019 and then will be repaid over the rest of the year. There was no dividend payment in 1Q 2018. In line with our current strategy of regular dividends 1Q 2019 will have a payout of 0.12THB
Consolidated Financial Statements for the third quarter of 2019, reviewed by auditor, to the Stock Exchange of Thailand. The clarification on the Company’s operating results for the third quarter of 2019, are as
Comparison is as follows: THB’000 Consolidated ∆% Separate ∆% 2017 2016 2017 2016 REVENUES FROM SALES AND SERVICES 2,473,795 3,672,528 -33% 1,631,566 1,812,983 -10% Interest income 1,045 1,896 -45% 36,148